121 related articles for article (PubMed ID: 37579618)
1. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry.
Arjona-Sanchez A; Aziz O; Passot G; Salti G; Serrano A; Esquivel J; Van der Speeten K; Sommariva A; Kazi M; Shariff U; Martínez-Regueira F; Piso P; Yonemura Y; Turaga K; Sgarbura O; Avanish Saklani A; Tonello M; Rodriguez-Ortiz L; Vazquez-Borrego MC; Romero-Ruiz A; Glehen O;
Eur J Surg Oncol; 2023 Oct; 49(10):107001. PubMed ID: 37579618
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
Arjona-Sanchez A; Aziz O; Passot G; Salti G; Esquivel J; Van der Speeten K; Piso P; Nedelcut DS; Sommariva A; Yonemura Y; Turaga K; Selvasekar CR; Rodriguez-Ortiz L; Sanchez-Hidalgo JM; Casado-Adam A; Rufian-Peña S; Briceño J; Glehen O
Eur J Surg Oncol; 2021 Jun; 47(6):1420-1426. PubMed ID: 33298341
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms.
Abudeeb H; Selvasekar CR; O'Dwyer ST; Chakrabarty B; Malcolmson L; Renehan AG; Wilson MS; Aziz O
Surg Endosc; 2020 Dec; 34(12):5516-5521. PubMed ID: 31993814
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.
Di Leo A; Corvasce A; Weindelmayer J; Mason EJ; Casella F; de Manzoni G
Updates Surg; 2020 Dec; 72(4):1207-1212. PubMed ID: 32410159
[TBL] [Abstract][Full Text] [Related]
5. An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Mercier F; Passot G; Bonnot PE; Cashin P; Ceelen W; Decullier E; Villeneuve L; Walter T; Levine EA; Glehen O; ;
World J Surg; 2022 Jun; 46(6):1336-1343. PubMed ID: 35286418
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma.
Mercier F; Jeremie G; Alyami M; Delphine V; Vahan K; Pascal R; Sylvie I; Guillaume P; Olivier G
Surg Endosc; 2020 Nov; 34(11):4916-4923. PubMed ID: 31792692
[TBL] [Abstract][Full Text] [Related]
7. Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review.
Martín-Román L; Hannan E; Faraz Khan M; Müller AS; Shields C; Aird J; Moran B; Mulsow J
Pleura Peritoneum; 2023 Jun; 8(2):65-74. PubMed ID: 37304162
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
9. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
Chang SC; Fingerhut A; Chen WT
Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.
Mercier F; Bakrin N; Bartlett DL; Goere D; Quenet F; Dumont F; Heyd B; Abboud K; Marolho C; Villeneuve L; Glehen O; ;
Ann Surg Oncol; 2018 Jun; 25(6):1668-1675. PubMed ID: 29637438
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic cytoreductive surgery and HIPEC in LAMN with small volume of peritoneal disease: a valuable option of treatment for good patient-related experience measures (PREMs).
Cusumano C; Carrere S; Bouillin A; Nougaret S; Khellaf L; Quénet F; Sgarbura O
Surg Endosc; 2022 Jul; 36(7):4757-4763. PubMed ID: 34845545
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Baratti D; Kusamura S; Milione M; Bruno F; Guaglio M; Deraco M
Ann Surg Oncol; 2018 Feb; 25(2):404-413. PubMed ID: 29159742
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP).
Manzanedo I; Pereira F; Cascales-Campos P; Muñoz-Casares C; Asensio E; Torres-Melero J; Prada-Villaverde A; Caravaca-García I; Gutiérrez-Calvo A; Vaqué J; Ortega G; Titos-García A; González-Sánchez L; Pérez-Viejo E; Serrano Á; Martínez-Torres B; Regecop Group
J Clin Med; 2023 May; 12(11):. PubMed ID: 37297969
[TBL] [Abstract][Full Text] [Related]
14. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience.
Santullo F; Pacelli F; Abatini C; Attalla El Halabieh M; Fortunato G; Lodoli C; Giovinazzo F; Rotolo S; Di Giorgio A
Front Surg; 2021; 8():715119. PubMed ID: 34513915
[No Abstract] [Full Text] [Related]
15. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Kusamura S; Barretta F; Yonemura Y; Sugarbaker PH; Moran BJ; Levine EA; Goere D; Baratti D; Nizri E; Morris DL; Glehen O; Sardi A; Barrios P; Quénet F; Villeneuve L; Gómez-Portilla A; de Hingh I; Ceelen W; Pelz JOW; Piso P; González-Moreno S; Van Der Speeten K; Deraco M;
JAMA Surg; 2021 Mar; 156(3):e206363. PubMed ID: 33502455
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.
Mercier F; Passot G; Villeneuve L; Levine EA; Yonemura Y; Goéré D; Sugarbaker PH; Marolho C; Bartlett DL; Glehen O;
Ann Surg Oncol; 2018 Apr; 25(4):1094-1100. PubMed ID: 29238881
[TBL] [Abstract][Full Text] [Related]
17. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (L-CRS/HIPEC) for Perforated Low-Grade Appendiceal Mucinous Neoplasm (LAMN II).
Parkin E; Selvasekar C; Wilson M; Renehan A; O'Dwyer S; Aziz O
Ann Surg Oncol; 2019 Jul; 26(7):2285. PubMed ID: 30989495
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis.
Shaltiel T; Solomon D; Pletcher ER; Golas BJ; Magge DR; Sarpel U; Labow DM; Cohen NA
Surg Endosc; 2022 Aug; 36(8):6153-6161. PubMed ID: 35080674
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis.
Cho CY; Veerapong J; Baumgartner JM; Murphy JD; Lowy AM; Kelly KJ
Surg Endosc; 2023 Jul; 37(7):5644-5651. PubMed ID: 36477643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
